Clinical trials was used to compare the effect of peppermint inhalation and Swedish massage on chemotherapy induced-nausea and vomiting in children with leukemia. the main research hypotheses are: * Children with leukemia who receive peppermint inhalation exhibit less chemotherapy induced- nausea and vomiting than those who don't receive. * Children with leukemia who receive Swedish massage exhibit less chemotherapy induced-nausea and vomiting than those who don't receive. * Children with leukemia who receive Swedish massage exhibit less chemotherapy induced- nausea and vomiting than those who receive peppermint inhalation. children divided into three groups of study ( control group, peppermint inhalation group and Swedish massage group) to identify its effect on chemotherapy induced nausea and vomiting.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
75
The researcher applied two drops (0,2ml) of 2% essential oil of peppermint on a piece of cotton. Then, each child was instructed to take three breaths of the essence that had been put on a piece of cotton before starting chemotherapy session with three minutes. In addition, the piece of cotton with peppermint essence was kept at bed side table to use by child as needed throughout the chemotherapy session. Inhalation of peppermint essence was applied for three consecutive chemotherapy sessions.
Children were received Swedish massage therapy for twenty minutes prior to chemotherapy session in a private and special room with effleurage, petrissage, friction, and tapotement and vibration movements for three consecutive chemotherapy sessions. The researcher applied facilitating olive oil in hands and pre warmed before applying massage. The massage technique was applied in prone position with mild to moderate pressure with guidance by the child's feedback and tolerance by using non-scented olive oil. Children's privacy was considered.
Eman Arafa Badr
Alexandria, Egypt
Experience of anticipatory nausea
Yes/No
Time frame: assessed immediately before chemotherapy administration for three consecutive chemotherapy sessions
Worst of anticipatory nausea
No/Mild/Moderate/severe/intolerable
Time frame: assessed immediately before chemotherapy administration for three consecutive chemotherapy sessions
Duration of anticipatory nausea
/Minutes
Time frame: assessed immediately before chemotherapy administration for three consecutive chemotherapy sessions
Frequency of anticipatory nausea
once/twice/ three times and more
Time frame: assessed immediately before chemotherapy administration for three consecutive chemotherapy sessions
Experience of anticipatory vomiting
Yes/No
Time frame: assessed immediately before chemotherapy administration for three consecutive chemotherapy sessions
Worst of anticipatory vomiting
No/Mild/Moderate/severe/intolerable
Time frame: assessed immediately before chemotherapy administration for three consecutive chemotherapy sessions
Amount of anticipatory vomiting
Small/ Moderate/ Large
Time frame: assessed immediately before chemotherapy administration for three consecutive chemotherapy sessions
Frequency of anticipatory vomiting
once/ twice/ three times and more.
Time frame: assessed immediately before chemotherapy administration for three consecutive chemotherapy sessions
Experience of acute nausea .
Yes/no.
Time frame: First 24 hours after first chemotherapy administration of study. Assessed within the first 24 hours after second chemotherapy administration of study. Assessed within the first 24 hours after third chemotherapy administration of study.
Worst of acute nausea .
No/Mild/Moderate/severe/intolerable
Time frame: First 24 hours after first chemotherapy administration of study. Assessed within the first 24 hours after second chemotherapy administration of study. Assessed within the first 24 hours after third chemotherapy administration of study.
Duration of acute nausea .
/hours.
Time frame: Frst 24 hours after first chemotherapy administration of study. Assessed within the first 24 hours after second chemotherapy administration of study. Assessed within the first 24 hours after third chemotherapy administration of study.
Frequency of acute nausea .
once/ twice/ three times and more.
Time frame: First 24 hours after first chemotherapy administration of study. Assessed within the first 24 hours after second chemotherapy administration of study. Assessed within the first 24 hours after third chemotherapy administration of study.
Experience of acute vomiting.
Yes/No.
Time frame: First 24 hours after first chemotherapy administration of study. Assessed within the first 24 hours after second chemotherapy administration of study. Assessed within the first 24 hours after third chemotherapy administration of study.
Worst of acute vomiting.
No/Mild/Moderate/severe/intolerable
Time frame: First 24 hours after first chemotherapy administration of study. Assessed within the first 24 hours after second chemotherapy administration of study. Assessed within the first 24 hours after third chemotherapy administration of study.
Amount of acute vomiting.
Small/ Moderate/ large
Time frame: First 24 hours after first chemotherapy administration of study. Assessed within the first 24 hours after second chemotherapy administration of study. Assessed within the first 24 hours after third chemotherapy administration of study.
Frequency of acute vomiting.
once/ twice/ three times and more.
Time frame: First 24 hours after first chemotherapy administration of study. Assessed within the first 24 hours after second chemotherapy administration of study. Assessed within the first 24 hours after third chemotherapy administration of study.
Experience of delayed nausea.
Yes/ No.
Time frame: On second and third days after first chemotherapy administration.On second and third days after second chemotherapy administration. On second and third days after third chemotherapy administration.
Worst of delayed nausea.
No/Mild/Moderate/severe/intolerable
Time frame: On second and third days after first chemotherapy administration.On second and third days after second chemotherapy administration. On second and third days after third chemotherapy administration.
Duration of delayed nausea.
/hours.
Time frame: On second and third days after first chemotherapy administration.On second and third days after second chemotherapy administration. On second and third days after third chemotherapy administration.
Frequency of delayed nausea.
once/ twice/ three times and more.
Time frame: On second and third days after first chemotherapy administration.On second and third days after second chemotherapy administration. On second and third days after third chemotherapy administration.
Experience of delayed vomiting.
Yes/ No.
Time frame: On second and third days after first chemotherapy administration.On second and third days after second chemotherapy administration. On second and third days after third chemotherapy administration.
Worst of delayed vomiting.
No/Mild/Moderate/severe/intolerable
Time frame: On second and third days after first chemotherapy administration.On second and third days after second chemotherapy administration. On second and third days after third chemotherapy administration.
Amount of delayed vomiting.
Small/ Moderate/ large
Time frame: On second and third days after first chemotherapy administration.On second and third days after second chemotherapy administration. On second and third days after third chemotherapy administration.
Frequency of delayed vomiting.
once/ twice/ three times and more.
Time frame: On second and third days after first chemotherapy administration.On second and third days after second chemotherapy administration. On second and third days after third chemotherapy administration.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.